Di-tert-butyl 4,7,10,13,16,19,22,25,28-nonaoxahentriacontanedioate, 97%, 250mg

4,4,5,5-Tetramethyl-2-(10-phenylanthracen-9-yl)-1,3,2-dioxaborolane>98.0%(GC)1g

(R)-2-(Methoxymethyl)azetidine, 95.0%, 100mg

N-(2,6-Dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)acetamide, 95.0%, 25g

Ethyl {[3-(trifluoromethyl)phenyl]carbamoyl}formate, 95+%, 1g

Ethyl 2-(2,4-difluorophenyl)-2,2-difluoroacetate, 95.0%, 1g

Ethyl 4-chloro-1H-pyrrolo[2,3-b]pyridine-5-carboxylate, 95.0%, 5g

(E)-1-chloro-3-(3-methoxystyryl)benzene, 95+%, 100mg

4'-Bromosalicylanilide>98.0%(T)5g

(4S,5S)-1,3-Bis(2-methoxyphenyl)-4,5-diphenyl-4,5-dihydro-1H-imidazol-3-ium tetrafluoroborate, 98%, 250mg

tert-Butylbenzene>98.0%(GC)500mL

tert-Butyl 4-(2,6-dichloropyridin-4-yl)piperidine-1-carboxylate, 97%, 250mg

(2-Propoxypyridin-3-yl)boronic acid, 98%, 100mg